Stories from people navigating muscle-invasive bladder cancer — diagnosis, treatment, caregiving, and the ordinary days in between.
2 stories
Oncology
The FDA expanded enfortumab vedotin plus pembrolizumab around cystectomy to adults with muscle-invasive bladder cancer regardless of cisplatin eligibility.
Rayan Salih · August 21, 2026 · 7 min
Oncology
Perioperative enfortumab vedotin plus pembrolizumab improved survival and pathologic complete response versus cisplatin–gemcitabine in cisplatin-eligible adults undergoing cystectomy.
Rayan Salih · 7 min read
Other conditions
One story a day
One health journey each morning — no advice, no alarm, just company for the road.